(FRAG (NP (NN Background)) (: :) (S (NP (NP (NP (QP (JJR More) (IN than) (NN half))) (-LRB- -LRB-) (NP (CD 57) (NN %)) (-RRB- -RRB-)) (PP (IN of) (NP (NN pharma) (JJ clinical) (NN research)))) (VP (VBP spend) (SBAR (S (VP (VBZ is) (PP (IN in) (NP (NP (NN support)) (PP (IN of) (NP (JJ clinical) (NNS trials)))))))))) (. .))
(FRAG (PRN (S (NP (CD One) (NN reason)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (NML (NNP Electronic) (NNP Health) (NNP Record) (-LRB- -LRB-) (NNP EHR) (-RRB- -RRB-)) (NNS systems)) (CC and) (NP (NN HIPAA) (NN privacy) (NNS rules))) (ADVP (RB often)) (VP (VBP limit) (SBAR (WHADVP (WRB how)) (S (NP (ADJP (RB broadly) (JJ patient)) (NN information)) (VP (MD can) (VP (VB be) (VP (VBN shared)))))))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ laborious) (JJ human) (NNS efforts))) (S (VP (TO to) (ADVP (RB manually)) (VP (VB collect)))))) (, ,) (S (ADJP (JJ de-identify))) (, ,) (CC and) (S (VP (VB summarize) (NP (JJ patient) (NN information)) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (JJ clinical) (NNS studies))))))) (. .))
(FRAG (NP (NN Purpose)) (: :) (FRAG (NP (NNP Conduct) (NN feasibility) (NN study)) (PP (IN for) (NP (DT a) (JJ Rheumatoid) (NN Arthritis))) (NP (-LRB- -LRB-) (NN RA) (-RRB- -RRB-)) (NP (NP (JJ clinical) (NN trial)) (PP (IN in) (NP (DT an) (NNP Accountable)))) (NP (NNP Care) (NNP Organization))) (. .))
(UCP (NP (NP (NN Measure) (NN prevalence)) (PP (IN of) (NP (NN RA)))) (CC and) (S (NP (JJ related) (NNS conditions)) (VP (VBG matching) (NP (NN study) (NNS criteria)))) (. .))
(S (VP (VB Evaluate) (NP (NP (NN automation)) (PP (IN of) (NP (JJ patient) (NN de-identification) (CC and) (NN summarization)))) (S (VP (TO to) (VP (VB support) (NP (JJ patient) (NN cohort) (NN development)) (PP (IN for) (NP (JJ clinical) (NNS studies))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (VP (VB Collect) (NP (JJ original) (JJ clinical) (NN documentation)) (ADVP (RB directly)) (PP (IN from) (NP (NP (DT the) (NML (NN provider) (NN EHR)) (NN system)) (CC and) (NP (NP (NN extract) (JJ clinical) (NNS concepts)) (ADJP (JJ necessary) (PP (IN for) (NP (VBG matching) (NN study) (NNS criteria))))))))) (. .))
(S (ADVP (RB Automatically)) (NP (NP (JJ de-identify) (VBN Protected) (NN Health) (NN Information)) (-LRB- -LRB-) (NP (NN PHI)) (-RRB- -RRB-)) (VP (VP (VBP protect) (NP (NN patient) (NN privacy))) (CC and) (VP (VB promote) (NP (NN sharing)))) (. .))
(NP (NP (NN Leverage)) (VP (VBG existing) (NP (NML (NN physician) (NN expert)) (NN knowledge) (NNS sources)) (S (VP (TO to) (VP (VB enable) (NP (NP (NN analysis)) (PP (IN of) (NP (JJ patient) (NNS populations)))))))) (. .))
(FRAG (NP (NNS Results)) (: :) (S (NP (NP (NN Prevalence)) (PP (IN of) (NP (NN RA)))) (VP (VBD was) (NP (NP (CD four) (NN percent) (PRN (-LRB- -LRB-) (NP (CD 4) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN study) (NN population)))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NML (NN age) (CD 53)) (NNS years)) (, ,) (NP (NML (CD 52) (NN %)) (NN female)) (, ,) (NP (NML (CD 48) (NN %)) (NN male))))) (-RRB- -RRB-)))) (. .))
(S (NP (NP (JJ Clinical) (NN documentation)) (PP (IN for) (NP (CD 3500) (NN patient)))) (VP (VBD were) (VP (VBN extracted) (PP (IN from) (NP (NML (NML (CD three) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (NN EHR)) (NNS systems))))) (. .))
(S (NP (VBN Grouped) (NN diagnosis) (NNS codes)) (VP (VBD revealed) (NP (NP (NP (JJ high) (NN prevalence)) (PP (IN of) (NP (NN diabetes)))) (CC and) (NP (NP (NNS diseases)) (PP (IN of) (NP (DT the) (JJ circulatory) (NN system))))) (, ,) (SBAR (IN as) (S (VP (VBN expected))))) (. .))
(S (NP (NN De-identification)) (ADVP (RB accurately)) (VP (VBD removed) (NP (NP (CD 99) (NN %)) (PP (IN of) (NP (NNP PHI) (NNS identifiers)))) (PP (IN with) (NP (NP (NML (CD 99) (NN %)) (NN sensitivity)) (CC and) (NP (NML (CD 99) (NN %)) (NN specificity))))) (. .))
(FRAG (NP (NNS Conclusions)) (: :) (S (NP (NNS Results)) (VP (VBP suggest) (SBAR (S (NP (DT the) (NN approach)) (VP (MD can) (VP (VP (VB improve) (NP (NN automation))) (CC and) (VP (VB accelerate) (NP (NP (NN planning) (CC and) (NN construction)) (PP (IN of) (NP (JJ new) (JJ clinical) (NNS studies)))) (PP (IN in) (NP (DT the) (NNP ACO) (NN setting)))))))))) (. .))
(S (NP (NN De-identification) (NN accuracy)) (VP (VBD was) (ADJP (ADJP (JJR better)) (PP (IN than) (NP (NP (ADJP (RB previously) (VBN approved)) (NNS requirements)) (VP (VBN defined) (PP (IN by) (NP (NML (NML (CD four) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-))) (NN hospital)) (JJ Institutional) (NN Review) (NNS Boards)))))))) (. .))
